Literature DB >> 2411951

Cytotoxic T-cell response to respiratory syncytial virus in mice.

C R Bangham, M J Cannon, D T Karzon, B A Askonas.   

Abstract

The role of the humoral and cellular arms of the immune response in protection against respiratory syncytial virus (RSV) infection and in the pathogenesis of the severe forms of this disease is poorly understood. The recent demonstration that some inbred mouse strains can be infected with RSV has opened the way to a detailed investigation of RSV immunity. We report here the finding of major histocompatibility complex-restricted, RSV-specific memory cytotoxic T cells in the spleens of BALB/c and C57BL mice after intranasal infection; these T cells recognize the Long, A2, and 8/60 (human) strains of RSV. Both K and D locus major histocompatibility complex alleles can restrict the cytotoxic response; however, in the two haplotypes tested, Dd is a low-responder allele and Kb is a nonresponder allele for RSV. UV-inactivated RSV (when given intraperitoneally) can prime mice for development of cytotoxic T cell memory, restimulate cytotoxic T cell cultures in vitro, and form a target for the cytotoxic cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411951      PMCID: PMC252469     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity.

Authors:  H J Zweerink; B A Askonas; D Millican; S A Courtneidge; J J Skehel
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

3.  Respiratory syncytial virus infection in inbred mice.

Authors:  G A Prince; R L Horswood; J Berndt; S C Suffin; R M Chanock
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins.

Authors:  A R Townsend; J J Skehel
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

Review 5.  An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses.

Authors:  G L Ada; K N Leung; H Ertl
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

6.  Classification of hybridomas to respiratory syncytial virus glycoproteins.

Authors:  B F Fernie; P J Cote; J L Gerin
Journal:  Proc Soc Exp Biol Med       Date:  1982-12

Review 7.  Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.

Authors:  K McIntosh; J M Fishaut
Journal:  Prog Med Virol       Date:  1980

8.  The development of Balb/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface.

Authors:  B F Fernie; E C Ford; J L Gerin
Journal:  Proc Soc Exp Biol Med       Date:  1981-05

9.  Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice.

Authors:  R G Webster; B A Askonas
Journal:  Eur J Immunol       Date:  1980-05       Impact factor: 5.532

10.  Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.

Authors:  P C Doherty; W E Biddison; J R Bennink; B B Knowles
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  38 in total

1.  HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein.

Authors:  A H Brandenburg; L de Waal; H H Timmerman; P Hoogerhout; R L de Swart; A D Osterhaus
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus.

Authors:  J E Fischer; J E Johnson; R K Kuli-Zade; T R Johnson; S Aung; R A Parker; B S Graham
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.

Authors:  J L Muñoz; C A McCarthy; M E Clark; C B Hall
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.

Authors:  C R Bangham; A J McMichael
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Rotavirus-specific protein synthesis is not necessary for recognition of infected cells by virus-specific cytotoxic T lymphocytes.

Authors:  P A Offit; H B Greenberg; K I Dudzik
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

Review 6.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.

Authors:  Y W Tang; B S Graham
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection.

Authors:  François Michaud; François Coulombe; Eric Gaudreault; Jasna Kriz; Jean Gosselin
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

10.  Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.

Authors:  Martin L Moore; Michael H Chi; Kasia Goleniewska; Joan E Durbin; R Stokes Peebles
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.